Cefepime (BMY-28142): Assay Design for CNS Models
2026-08-07
Cefepime (BMY-28142) supports more than broad-spectrum antimicrobial testing. This guide presents an assay-centered framework for central nervous system infection research, neurotoxicity studies, barrier models, and resistance-aware interpretation.
NHE1 in Macrophages Drives Octanal/Olfr2-Linked Atherosclero
2026-08-07
This study elucidates how macrophage NHE1 mediates atherosclerosis progression in response to octanal/Olfr2 signaling, highlighting calcium-dependent ROS and NLRP3 inflammasome activation as critical mechanisms. These findings open new avenues for anti-atherosclerotic strategies targeting macrophage signaling pathways.
Monomeric Amyloid Beta Regulates Microglia During Brain Deve
2026-08-06
This study uncovers a novel signaling pathway by which monomeric amyloid beta-peptide (Aβ) regulates microglial activity in the developing brain, highlighting a physiological role distinct from its established pathogenic effects in Alzheimer's disease. The findings suggest that depletion of Aβ monomer may contribute to disease pathology, opening new avenues for targeted research and experimental modeling.
Optimizing Membrane Protein Assays with n-Dodecyl-β-D-maltos
2026-08-06
This scenario-driven article guides biomedical researchers through persistent challenges in membrane protein biochemistry, demonstrating how n-Dodecyl-β-D-maltoside (DDM, SKU C4421) from APExBIO delivers reliable, reproducible solutions. Using real-world Q&A, it covers conceptual pitfalls, experimental design, and vendor selection—grounding every recommendation in evidence and practical experience.
Applied Cancer Workflows Using JNJ-26481585 (Quisinostat)
2026-08-05
Leverage JNJ-26481585 (Quisinostat) to overcome TRIM21-driven tumor resistance and induce apoptosis in diverse cancer models. This guide details advanced protocols, troubleshooting insights, and practical enhancements for epigenetic modulation in preclinical research.
Mitochondrial Permeability Transition Pore Assay Kit: Applie
2026-08-05
Unlock precise mitochondrial permeability transition pore detection with the Mitochondrial Permeability Transition Pore Assay Kit. Explore robust, fluorescence-based workflows for apoptosis and necrosis studies, plus practical troubleshooting for advanced cell death mechanism research.
Disabling Tumor Extracellular Vesicles to Inhibit Metastasis
2026-08-04
A recent Nature Cancer study demonstrates a lipidated nanophotosensitizer that selectively traces and disables tumor extracellular vesicles (TEVs), achieving concurrent suppression of tumor growth and metastasis in preclinical models. This innovative approach provides mechanistic insight into targeting TEV-mediated communication—an important driver of metastasis—while highlighting practical challenges in specificity and translation.
Hoechst 33258: Optimizing Bis-Benzimide DNA Stain Workflows
2026-08-04
Hoechst 33258, a versatile bis-benzimide DNA stain, empowers high-precision DNA visualization in both live and fixed cells, uniquely supporting advanced studies on tumor heterogeneity and cell mechanics. This article delivers practical protocols, troubleshooting strategies, and real-world workflow enhancements for researchers tackling complex oncology and cell cycle analysis challenges.
Moxibustion Enhances Axonal Regeneration via PI3K/Akt Pathwa
2026-08-03
This study demonstrates that moxibustion promotes axonal regeneration and improves learning and memory in a rat model of post-stroke cognitive impairment by activating the PI3K/Akt signaling pathway and regulating TACC3. The findings provide mechanistic insight into traditional therapies and highlight the role of pathway-specific inhibitors in dissecting neuroregenerative processes.
SNS-032 (BMS-387032): Precision CDK9 Inhibition in Oncology
2026-08-03
Explore how SNS-032 (BMS-387032) enables advanced research in cell cycle regulation, apoptosis induction in cancer cells, and host-targeted antiviral strategies. This in-depth article reveals unique mechanistic insights and practical guidance not covered in existing content.
Hypoxia, Immunometabolism, and Redox State in Tumor Microenv
2026-08-02
This review dissects how hypoxia-driven metabolic reprogramming and immune cell adaptation jointly shape the immunosuppressive tumor microenvironment. By detailing the mechanisms linking oxygen deprivation, metabolic competition, and immune evasion, it provides a mechanistic foundation for targeting immunometabolism in future cancer therapies.
Salvianolic acid B: Optimizing Pulmonary Fibrosis Research W
2026-08-01
Salvianolic acid B (Dan Shen Suan B) is redefining pulmonary fibrosis research by targeting LH2-mediated collagen cross-linking, providing a precise, high-purity tool for extracellular matrix remodeling studies. This article translates the latest experimental breakthroughs into actionable protocols, troubleshooting strategies, and comparative advantages to maximize the impact of this natural antifibrotic agent.
APEX2 Controls TERT Expression in Human Embryonic Stem Cells
2026-07-31
The reference study uncovers a previously unknown role for APEX2 in regulating telomerase reverse transcriptase (TERT) expression in human embryonic stem cells. This finding links DNA repair enzyme activity at repetitive elements to telomerase regulation, with implications for stem cell maintenance and cancer biology.
Leucomycin (Kitasamycin): Biosynthetic Insights & Assay Desi
2026-07-31
Explore the biosynthetic pathway and resistance mechanisms of Leucomycin (kitasamycin), a potent macrolide antibiotic. This article uniquely connects polyketide biosynthesis, advanced assay design, and resistance profiling to empower translational inhibition research.
Tacrine-Based Hybrids: Multi-Target Strategies in Alzheimer’
2026-07-30
This review synthesizes advances in the design of tacrine-based hybrid molecules for Alzheimer's disease, highlighting their multi-target mechanisms and progress in reducing toxicity. The reference study provides a comprehensive analysis of how modifications to the Tacrine scaffold enable more effective and safer therapeutic candidates for neurodegenerative disease research.
457 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page